Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 26% ± 8% | |
microglial cell | 10 studies | 52% ± 23% | |
oligodendrocyte | 9 studies | 32% ± 17% | |
macrophage | 8 studies | 34% ± 6% | |
astrocyte | 7 studies | 33% ± 20% | |
oligodendrocyte precursor cell | 5 studies | 31% ± 9% | |
ciliated cell | 4 studies | 23% ± 7% | |
epithelial cell | 4 studies | 27% ± 3% | |
glutamatergic neuron | 4 studies | 41% ± 25% | |
GABAergic neuron | 3 studies | 43% ± 24% | |
retinal rod cell | 3 studies | 22% ± 2% | |
pericyte | 3 studies | 22% ± 8% | |
myeloid cell | 3 studies | 35% ± 9% | |
T cell | 3 studies | 25% ± 8% | |
monocyte | 3 studies | 42% ± 14% | |
type II pneumocyte | 3 studies | 27% ± 5% | |
dendritic cell | 3 studies | 31% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 144.38 | 1445 / 1445 | 66% | 1.16 | 120 / 183 |
intestine | 100% | 118.32 | 966 / 966 | 48% | 0.86 | 254 / 527 |
stomach | 99% | 60.75 | 354 / 359 | 48% | 1.10 | 137 / 286 |
skin | 100% | 183.05 | 1808 / 1809 | 43% | 0.81 | 201 / 472 |
bladder | 100% | 83.57 | 21 / 21 | 30% | 0.72 | 150 / 504 |
lung | 99% | 85.00 | 571 / 578 | 29% | 0.60 | 336 / 1155 |
pancreas | 97% | 62.02 | 319 / 328 | 24% | 0.57 | 42 / 178 |
uterus | 99% | 83.67 | 169 / 170 | 17% | 0.31 | 80 / 459 |
brain | 96% | 60.37 | 2527 / 2642 | 17% | 0.25 | 123 / 705 |
breast | 99% | 69.67 | 454 / 459 | 14% | 0.28 | 151 / 1118 |
thymus | 100% | 102.18 | 652 / 653 | 8% | 0.14 | 51 / 605 |
kidney | 100% | 112.63 | 89 / 89 | 6% | 0.12 | 58 / 901 |
prostate | 100% | 113.50 | 245 / 245 | 1% | 0.03 | 4 / 502 |
adrenal gland | 100% | 101.83 | 257 / 258 | 0% | 0.00 | 1 / 230 |
spleen | 100% | 111.34 | 241 / 241 | 0% | 0 | 0 / 0 |
liver | 96% | 73.27 | 218 / 226 | 3% | 0.04 | 12 / 406 |
blood vessel | 99% | 74.30 | 1323 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 91.33 | 784 / 803 | 0% | 0 | 0 / 0 |
adipose | 97% | 58.18 | 1167 / 1204 | 0% | 0 | 0 / 0 |
ovary | 88% | 39.51 | 158 / 180 | 7% | 0.10 | 32 / 430 |
heart | 94% | 91.59 | 806 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 79.96 | 800 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.12 | 3 / 29 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.10 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005515 | Molecular function | protein binding |
Gene name | DLEU1 |
Protein name | Leukemia-associated protein 1 (Deleted in lymphocytic leukemia 1) (HBV X-transactivated gene 6 protein) (HBV XAg-transactivated protein 6) DLEU1 protein (cDNA, FLJ92453, Homo sapiens deleted in lymphocytic leukemia, 1 (DLEU1), mRNA) |
Synonyms | LEU1 XTP6 |
Description | FUNCTION: May act as a tumor suppressor. |
Accessions | Q6ICR8 O43261 |